Literature DB >> 8662903

Ku80-deficient cells exhibit excess degradation of extrachromosomal DNA.

F Liang1, M Jasin.   

Abstract

Mammalian cells possess a protein complex, termed DNA-PK, which binds to DNA double strand breaks in vitro. The complex consists of the heterodimeric Ku autoantigen and a DNA-dependent protein kinase, DNA-PKcs. Cell lines that are deficient for components of this complex are sensitive to ionizing radiation and have impaired V(D)J recombination, a site-specific recombination process. We have tested these cell lines for their ability to repair double strand breaks in transfected DNA. The xrs-6 cell line, which is deficient for the 80-kDa subunit of the Ku autoantigen, exhibited reduced stability of transfected DNA. Prior to obvious reductions in DNA stability, the levels of homologous recombination and DNA end joining were unaffected. However, the recovery of end joining products with precisely joined ends was reduced, with a concomitant increase in products containing deletions. Unlike the Ku80-deficient cells, no reduction in DNA stability was detected in DNA-PKcs-deficient scid cells. Scid cells also exhibited normal levels of homologous recombination and DNA end joining. These experiments implicate the Ku autoantigen, but not DNA-PKcs, in a direct role in protecting DNA ends from degradation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662903     DOI: 10.1074/jbc.271.24.14405

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining.

Authors:  E Feldmann; V Schmiemann; W Goedecke; S Reichenberger; P Pfeiffer
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

Review 2.  Manipulating the mammalian genome by homologous recombination.

Authors:  K M Vasquez; K Marburger; Z Intody; J H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

3.  Ku DNA end-binding protein modulates homologous repair of double-strand breaks in mammalian cells.

Authors:  A J Pierce; P Hu; M Han; N Ellis; M Jasin
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

4.  An xrcc4 defect or Wortmannin stimulates homologous recombination specifically induced by double-strand breaks in mammalian cells.

Authors:  Fabien Delacôte; Mingguang Han; Thomas D Stamato; Maria Jasin; Bernard S Lopez
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

5.  DNA end joining becomes less efficient and more error-prone during cellular senescence.

Authors:  Andrei Seluanov; David Mittelman; Olivia M Pereira-Smith; John H Wilson; Vera Gorbunova
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-28       Impact factor: 11.205

6.  Initiation of DNA double strand break repair: signaling and single-stranded resection dictate the choice between homologous recombination, non-homologous end-joining and alternative end-joining.

Authors:  Anastazja Grabarz; Aurélia Barascu; Josée Guirouilh-Barbat; Bernard S Lopez
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

7.  ATM regulates Mre11-dependent DNA end-degradation and microhomology-mediated end joining.

Authors:  Elias A Rahal; Leigh A Henricksen; Yuling Li; R Scott Williams; John A Tainer; Kathleen Dixon
Journal:  Cell Cycle       Date:  2010-07-12       Impact factor: 4.534

Review 8.  Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis.

Authors:  Mary Ellen Moynahan; Maria Jasin
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03       Impact factor: 94.444

Review 9.  BRCA1 Mutation: A Predictive Marker for Radiation Therapy?

Authors:  Charlene Kan; Junran Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-01       Impact factor: 7.038

10.  DNA end-joining catalyzed by human cell-free extracts.

Authors:  P Baumann; S C West
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.